1. Medtech Insight
  2. >>Digital Technologies

Pear Therapeutics Adds Two PDTs To Treat Depression

 
• By Reed Miller

Pear Therapeutics acquired a digital therapeutic for depression from Waypoint Health and licensed an Internet-based cognitive behavior therapy program for residual symptoms of depression from a psychologist in Sweden.

• Source: Alamy

Pear Therapeutics is adding depression to the growing list of conditions addressed by its cognitive behavioral therapy (CBT) prescription digital therapeutic (PDTs) technology.

A recent study, led by Catherine Ettman of Boston University, showed that about a third of US adults experienced depressive...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

Execs On The Move: June 16–20, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Dxcover Launches US Operations With New Headquarters In Tennessee

 
• By Natasha Barrow

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

EnsoData Boosts AI Sleep Tech With $20M Series B Funding, Targets Underdiagnosis Crisis

 
• By Shubham Singh

EnsoData positions itself as device-agnostic and interoperable, with FDA-cleared software that can integrate with all major devices. CEO Mortara said this flexibility helps maximize patient reach by enabling both direct provider engagement and integration with device manufacturers.